FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Liver fibrosis is a life-threatening pathological anomaly which usually evolves into advanced liver cirrhosis and hepatocellular carcinoma although limited therapeutic option is readily available. FUN14 domain containing 1 (FUNDC1) is a mitophagy receptor with little information in liver fibrosis. OBJECTIVE: This study was designed to examine the role for FUNDC1 in carbon tetrachloride (CCl4)-induced liver injury. METHODS: GEO database analysis and subsequent validation of biological processes including western blot, immunofluorescence, and co-immunoprecipitation were applied to clarify the regulatory role of FUNDC1 on mitophagy and ferroptosis. RESULTS: Our data revealed elevated FUNDC1 levels in liver tissues of patients with liver fibrotic injury and CCl4-challenged mice. FUNDC1 deletion protected against CCl4-induced hepatic anomalies in mice. Moreover, FUNDC1 deletion ameliorated CCl4-induced ferroptosis in vivo and in vitro. Mechanically, FUNDC1 interacted with glutathione peroxidase (GPx4), a selenoenzyme to neutralize lipid hydroperoxides and ferroptosis, via its 96-133 amino acid domain to facilitate GPx4 recruitment into mitochondria from cytoplasm. GPx4 entered mitochondria through mitochondrial protein import system-the translocase of outer membrane/translocase of inner membrane (TOM/TIM) complex, prior to degradation of GPx4 mainly through mitophagy along with ROS-induced damaged mitochondria, resulting in hepatocyte ferroptosis. CONCLUSION: Taken together, our data favored that FUNDC1 promoted hepatocyte injury through GPx4 binding to facilitate its mitochondrial translocation through TOM/TIM complex, where GPx4 was degraded by mitophagy to trigger ferroptosis. Targeting FUNDC1 may be a promising therapeutic approach for liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
González‐Fernández, B., Sánchez, D. I., Crespo, I., San‐Miguel, B., de Urbina, J. J. O., González‐Gallego, J., & Tuñón, M. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00556 · Cited by 38 · cited 1×
“Liver fibrosis was established using an intraperitoneal injection of CCl4 (Sigma-Aldrich, St. Louis, MO, USA; 1:4 v/v in corn oil) at a dosage of 5 mL/kg of body weight (BW) twice per week for 4 weeks, a widely perceived model of liver fibrosis in rodents [36].”
MethodRetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · cited 1×
“Ferroptosis is a new form of iron-dependent regulated cell death, resulting from accumulation of reactive oxygen species (ROS) and lipid peroxidation [19,20].”
BackgroundRegulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 1×
“GPx4 is an essential antioxidant enzyme to resist ferroptosis through reduction of hydroperoxide-associated membranes [33,53].”
BackgroundThe CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703 · cited 1×
“Glutathione peroxidase 4 (GPx4) is a glutathione peroxidase that utilizes glutathione (GSH) as a cofactor to convert lipid hydroperoxides into non-toxic lipid alcohols to mitigate fer-roptosis [29].”
BackgroundFerroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 1×
“Previous findings have indicated involvement of ferroptosis in a wide variety of pathological processes including cancers, liver and cardiovascular diseases [22– 25].”
BackgroundRole of Mitochondria in Ferroptosis
Gao, M., Yi, J., Zhu, J., Minikes, A. M., Monian, P., Thompson, C. B., & Jiang, X. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.042 · Cited by 2,120 · cited 2×
“Morphological alterations including mitochondrial fragmentation and cristae enlargement were noted in mitochondria under ferroptosis [26].”
BackgroundSeiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470 · cited 1×
“Downregulation or depletion of GPx4 evokes accumulation of lipid peroxides and other reactive oxygen species, resulting in cell ferroptosis [23,30].”
BackgroundCalabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796 · cited 1×
“Several essential cellular defense pathways including sirtuin, nuclear factor erythroid-derived 2 (Nrf2) and related cell signaling pathways appear to integrate adaptive stress responses in the combat against proinflammatory response to off-set ferroptosis [51,52].”
BackgroundRSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
Sui, X., Zhang, R., Liu, S., Duan, T., Zhai, L., Zhang, M., Han, X., Xiang, Y., Huang, X., Lin, H., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01371 · Cited by 703 · cited 1×
“A GPx4 inhibitor Ras-selective lethal small molecule 3 (RSL3, 1 uM for 24 hrs) was thus added to CCl4 treated-E47 cells with FUNDC1 knockdown [46].”
MethodSelf-citationmTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
Zhang, Y., Swanda, R. V., Nie, L., Liu, X., Wang, C., Lee, H., Lei, G., Mao, C., Koppula, P., Cheng, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21841-w · Cited by 698 · cited 1×
“It is unique in morphology, biochemistry, and genetics in comparison with other forms of regulated cell death (RCD) [21].”
BackgroundSelf-citationGoldberg, D., Ditah, I. C., Saeian, K., Lalehzari, M., Aronsohn, A., Gorospe, E. C., & Charlton, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.003 · Cited by 604 · cited 1×
“It is mainly provoked by hepatic stresses including viral hepatitis, nonalcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), iron overload syndrome, hereditary haemochromatosis, and diabetes mellitus [2,3].”
BackgroundHepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
Yu, Y., Jiang, L., Wang, H., Shen, Z., Cheng, Q., Zhang, P., Wang, J., Wu, Q., Fang, X., Duan, L., et al. (2020) · Blood · doi:10.1182/blood.2019002907 · Cited by 601 · cited 1×
“Our study also found that CCl4 challenge led to hepatocyte ferroptosis, in line with an earlier report [24].”
ResultULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy
Wu, W., Tian, W., Hu, Z., Chen, G., Huang, L., Li, W., Zhang, X., Xue, P., Zhou, C., Liu, L., et al. (2014) · The EMBO Reports · doi:10.1002/embr.201438501 · Cited by 574 · cited 1×
“FUNDC1 is a ubiquitin-independent mitophagy receptor regulating multiple chronic pathological processes including liver diseases [14,18,48,49].”
BackgroundBasit, F., van Oppen, L. M., Schöckel, L., Bossenbroek, H. M., van Emst-de Vries, S. E., Hermeling, J. C., Grefte, S., Kopitz, C., Heroult, M., HGM Willems, P., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.133 · Cited by 565 · cited 1×
“…observed using TEM in vivo, and MitoKeima in vitro) may contribute to hepatocyte ferroptosis in the face of CCl4 challenge, consistent with earlier findings that mitophagy promotes lipid peroxidation-induced ferroptosis through degradation of cargo contents within the cell [50,51,55,56].”
BackgroundWei, S., Qiu, T., Yao, X., Wang, N., Jiang, L., Jia, X., Tao, Y., Wang, Z., Pei, P., Zhang, J., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121390 · Cited by 379 · cited 1×
“Furthermore, ferroptosis inhibitors were reported to exquisitely target mitochondria, consistent with the potential involvement of mitochondria in ferroptosis process [27,28].”
BackgroundSelf-citationPark, T.-J., Park, J. H., Lee, G. S., Lee, J.-Y., Shin, J. H., Kim, M. W., Kim, Y. S., Kim, J.-Y., Oh, K.-J., Han, B.-S., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2061-8 · Cited by 364 · cited 1×
“Downregulation or depletion of GPx4 evokes accumulation of lipid peroxides and other reactive oxygen species, resulting in cell ferroptosis [23,30].”
BackgroundWu, W., Lin, C., Wu, K., Jiang, L., Wang, X., Li, W., Zhuang, H., Zhang, X., Chen, H., Li, S., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593102 · Cited by 360 · cited 1×
“FUNDC1 is a ubiquitin-independent mitophagy receptor regulating multiple chronic pathological processes including liver diseases [14,18,48,49].”
BackgroundLi, R., Xin, T., Li, D., Wang, C., Zhu, H., & Zhou, H. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.011 · Cited by 352 · cited 1×
“BCL2 interacting protein 3 like (BNIP3) is a mito-phagy receptor highly expressed in the liver and directly interacts with microtubule-associated light chain 3 (LC3) to initiate mito-phagy [10,11].”
BackgroundQi, J., Kim, J.-W., Zhou, Z., Lim, C.-W., & Kim, B. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.09.011 · Cited by 338 · cited 1×
“In addition, FUNDC1 -/- mice were intraperitoneally injected with RSL3 (2.5 mg/kg, once a day for 10 days) [47].”
MethodInfluentialFerritinophagy and ferroptosis in the management of metabolic diseases
Ajoolabady, A., Aslkhodapasandhokmabad, H., Libby, P., Tuomilehto, J., Lip, G. Y. H., Penninger, J. M., Richardson, D. R., Tang, D., Zhou, H., Wang, S., et al. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.04.010 · Cited by 334 · cited 1×
“Previous findings have indicated involvement of ferroptosis in a wide variety of pathological processes including cancers, liver and cardiovascular diseases [22– 25].”
BackgroundSelf-citationYao, J., Wang, J., Xu, Y., Guo, Q., Sun, Y., Liu, J., Li, S., Guo, Y., & Wei, L. (2022) · Autophagy · doi:10.1080/15548627.2021.2007027 · Cited by 267 · cited 2×
“To further examine the role of mitophagy in ferroptosis, orox-ylin A (OA, 150 l M for 48 hrs), a mitophagy inhibitor targeting Pink1/Parkin-and BNIP3-mediated mitophagy [10], was added prior to CCl4 challenge in E47 cells.”
BackgroundMethodKang, J., Hong, J., & Lee, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12319 · Cited by 231 · cited 2×
“Mitophagy was reported to promote tissue damage in the face of carbon tetrachlo-ride (CCl4) insult [7–9].”
BackgroundQi, W., Li, Z., Xia, L., Dai, J., Zhang, Q., Wu, C., & Xu, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52837-8 · Cited by 226 · cited 1×
“To further decipher if the beneficial action of FUNDC1 defi-ciency against CCl4-induced liver injury involved ferroptosis, the ferroptosis inducer erastin was employed (10 l M for 24 hrs) [43,44] in E47 cells.”
MethodWang, J., Zhu, P., Li, R., Ren, J., & Zhou, H. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101415 · Cited by 221 · cited 1×
“FUN14 domain-containing protein 1 (FUNDC1) is a new mitophagy receptor through direct interaction with LC3 motif in a fashion reminiscent of BNIP3 [12,13].”
BackgroundSelf-citationThe metabolomic window into hepatobiliary disease
Beyoğlu, D., & Idle, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.030 · Cited by 215 · cited 1×
“It is mainly provoked by hepatic stresses including viral hepatitis, nonalcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), iron overload syndrome, hereditary haemochromatosis, and diabetes mellitus [2,3].”
BackgroundInterplay Between Lipid Metabolism and Autophagy
Xie, Y., Li, J., Kang, R., & Tang, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00431 · Cited by 203 · cited 2×
“…observed using TEM in vivo, and MitoKeima in vitro) may contribute to hepatocyte ferroptosis in the face of CCl4 challenge, consistent with earlier findings that mitophagy promotes lipid peroxidation-induced ferroptosis through degradation of cargo contents within the cell [50,51,55,56].”
BackgroundYang, W., Wang, Y., Zhang, C., Huang, Y., Yu, J., Shi, L., Zhang, P., Yin, Y., Li, R., & Tao, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865689 · Cited by 201 · cited 1×
“Besides, GPx4 activation was shown to protect against ferroptosis-induced liver injury in mice [32].”
BackgroundLiang, H., Yoo, S.-E., Na, R., Walter, C. A., Richardson, A., & Ran, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032839 · Cited by 190 · cited 6×
“Therefore, in pathological conditions with evident mitochondrial damage including mtROS production and increased mitochondrial permeability, GPx4 is prone to recruitment and translocation into mitochondria though the subsequent fate remains uncertain [33,35].”
BackgroundMethodInfluentialLiu, M., Fan, Y., Li, D., Han, B., Meng, Y., Chen, F., Liu, T., Song, Z., Han, Y., Huang, L., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12936 · Cited by 187 · cited 1×
“Selective autophagy including mitophagy was recently suggested to interplay with ferroptosis in a ROS-dependent way [45].”
BackgroundZhou, H., Zhu, P., Wang, J., Toan, S., & Ren, J. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0094-1 · Cited by 183 · cited 3×
“In addition, downregulation of FUNDC1 suppressed mitophagy in alcoholic liver diseases, which activated the DNA-dependent protein kinase catalytic subunit (DNA-PKcs)- p53-dynamin-related protein 1 (Drp1) signaling cascade, leading to unchecked mitochondrial fission and liver injury [14].”
BackgroundSelf-citationLi, W., Li, Y., Siraj, S., Jin, H., Fan, Y., Yang, X., Huang, X., Wang, X., Wang, J., Liu, L., et al. (2019) · Hepatology · doi:10.1002/hep.30191 · Cited by 178 · cited 2×
“Data from our group and others have noted a pivotal role for FUNDC1 in the maintenance of hepatic homeostasis [14,15].”
BackgroundDabkowski, E. R., Williamson, C. L., & Hollander, J. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.021 · Cited by 170 · cited 1×
“Other than retardation against lipid peroxidation, GPx4 exerts a mitochondrial protective role by regulating mitochondrial apoptosis and mitochondrial energy metabolism [33,54].”
BackgroundCytotoxicity and Apoptosis Produced by Cytochrome P450 2E1 in Hep G2 Cells
Chen, Q., & Cederbaum, A. I. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.638 · Cited by 163 · cited 2×
“Given that CCl4-induced hepatotoxicity is predominantly mediated through Cyp2E1 metabolism to yield CCl3 radical, HepG2 cell lines overexpressing CYP2E1 (E47 line) are deemed a useful model to discern the biochemical properties of CYP2E1 [37].”
BackgroundMethodStructural basis for the phosphorylation of FUNDC1 LIR as a molecular switch of mitophagy
Kuang, Y., Ma, K., Zhou, C., Ding, P., Zhu, Y., Chen, Q., & Xia, B. (2016) · Autophagy · doi:10.1080/15548627.2016.1238552 · Cited by 155 · cited 1×
“FUN14 domain-containing protein 1 (FUNDC1) is a new mitophagy receptor through direct interaction with LC3 motif in a fashion reminiscent of BNIP3 [12,13].”
BackgroundA Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering
To, T., Cuadros, A. M., Shah, H., Hung, W. H. W., Yang, L., Kim, S. H., Rubin, D. H. F., Boe, R. H., Rath, S. P., Eaton, J. K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.032 · Cited by 148 · cited 2×
“Therefore, in pathological conditions with evident mitochondrial damage including mtROS production and increased mitochondrial permeability, GPx4 is prone to recruitment and translocation into mitochondria though the subsequent fate remains uncertain [33,35].”
BackgroundLuo, J., Zhang, P., Zhao, T., Jia, M., Yin, P., Li, W., Zhang, Z.-R., Fu, Y., & Gong, T. (2019) · ACS Nano · doi:10.1021/acsnano.8b06924 · Cited by 148 · cited 2×
“…and cell signaling pathways involved in liver fibrosis, removal of FUNDC1 using an engineered model protected against CCl4-induced liver damage and ferroptosis, without obvious effect on cytochrome P450 enzyme activities – which mediates CCl4 metabolism and participates in CCl4 toxicity [40–42].”
MethodInfluentialRen, J., Sun, M., Zhou, H., Ajoolabady, A., Zhou, Y., Tao, J., Sowers, J. R., & Zhang, Y. (2020) · Science Advances · doi:10.1126/sciadv.abc8561 · Cited by 137 · cited 3×
“Our study reported an essential role for FUNDC1 in preserving mitochondrial Ca 2+ homeostasis and cardiac function in obese hearts through its interaction with the ubiquitin E3 ligase FBXL2 [18].”
BackgroundMethodSelf-citationMicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells
Bai, T., Liang, R., Zhu, R., Wang, W., Zhou, L., & Sun, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29496 · Cited by 125 · cited 1×
“To further decipher if the beneficial action of FUNDC1 defi-ciency against CCl4-induced liver injury involved ferroptosis, the ferroptosis inducer erastin was employed (10 l M for 24 hrs) [43,44] in E47 cells.”
MethodLi, Y., Xue, Y., Xu, X., Wang, G., Liu, Y., Wu, H., Li, W., Wang, Y., Chen, Z., Zhang, W., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201798786 · Cited by 122 · cited 3×
“FUNDC1 was reported to interact with certain cytoplastic proteins, to foster their mitochondrial translocation through the TOM/TIM complex for further degradation using the degradation system within mitochondrial matrix, uncovering a new functional category for FUNDC1 [16].”
BackgroundSelf-citationEzea, P. C., Swan, D., Shanley, D. P., & Hesketh, J. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.029 · Cited by 110
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing
Ajoolabady, A., Aslkhodapasandhokmabad, H., Aghanejad, A., Zhang, Y., & Ren, J. T. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101129 · Cited by 106 · cited 1×
“Mitophagy, a selective form of autophagy, governs mitochondrial turnover and recycling to maintain hepatic homeostasis through removal of long-lived/damaged mitochondria [6].”
BackgroundSelf-citationThe Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2
Yang, W., Lin, C., Wu, J., Chao, P.-Y., Chen, K., Chen, P., & Chi, J. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0534 · Cited by 106 · cited 1×
“Ferroptosis is a new form of iron-dependent regulated cell death, resulting from accumulation of reactive oxygen species (ROS) and lipid peroxidation [19,20].”
BackgroundLemmer, A., VanWagner, L. B., & Ganger, D. R. (2018) · Hepatology · doi:10.1002/hep.30048 · Cited by 98 · cited 1×
“…liver failure, cirrhosis, and hepatocellular carcinoma ensue, imposing a major threat for human health although little effective treatment remedy is readily available for patients with advanced liver fibrosis beyond liver transplantation due to its poorly defined underlying mechanism(s) [4,5].”
BackgroundHan, J., He, Y., Zhao, H., & Xu, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28734 · Cited by 97
Mitophagy in the Pathogenesis of Liver Diseases
Ke, P. (2020) · Cells · doi:10.3390/cells9040831 · Cited by 94
Redox regulation of cellular stress response in neurodegenerative disorders.
Calabrese, V., Guagliano, E., Sapienza, M. A., Mancuso, C., Butterfield, D. A., & Stella, A. M. G. (2006) · PubMed · Cited by 87
Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine
Bento, G., Shafigullina, A. K., Rizvanov, A. A., Sardão, V. A., Macedo, M. P., & Oliveira, P. J. (2020) · Cells · doi:10.3390/cells9030573 · Cited by 83 · cited 2×
“For example, FUNDC1 participates in mitochondrial reprogramming and cellular plasticity through interacting with Lon protease 1 (LonP1), a member of protein folding quality control system on the mitochondrial inner membrane to manage proteolytic disposal of misfolded and aggregated proteins [17].”
BackgroundMa, X., Luo, Q., Zhu, H., Liu, X., Dong, Z., Zhang, K., Zou, Y., Wu, J., Ge, J., & Sun, A. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13677 · Cited by 70 · cited 2×
“Mitophagy was reported to promote tissue damage in the face of carbon tetrachlo-ride (CCl4) insult [7–9].”
BackgroundWang, S., Tao, J., Chen, H., Kandadi, M. R., Sun, M., Xu, H., Lopaschuk, G. D., Lü, Y., Zheng, J., Hu, P., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.006 · Cited by 66 · cited 1×
“Films were scanned and detected with a Bio-Rad calibrated densit-ometer [38].”
MethodSelf-citationNežić, L., Škrbić, R., Amidžić, L., Gajanin, R., Milovanovic, Z. A., Nepovimová, E., Kuča, K., & Jacevic, V. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197236 · Cited by 48 · cited 1×
“Furthermore, ferroptosis inhibitors were reported to exquisitely target mitochondria, consistent with the potential involvement of mitochondria in ferroptosis process [27,28].”
BackgroundFerroptosis: the Good, the Bad and the Ugly
Aldrovandi, M., & Conrad, M. (2020) · Cell Research · doi:10.1038/s41422-020-00434-0 · Cited by 45 · cited 1×
“Excessive hepatic iron deposition and ferroptosis is speculated to potentiate liver fibrosis in mice, the process of which can be reversed by ferrostatin-1 [31].”
BackgroundSVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes
Jia, D. T., Wang, Y. Y., Wang, P., Huang, Y., Wang, D., Wang, D., Zhang, C., Zhang, C., Guo, L., Liang, P., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1311-0 · Cited by 36 · cited 2×
“…and cell signaling pathways involved in liver fibrosis, removal of FUNDC1 using an engineered model protected against CCl4-induced liver damage and ferroptosis, without obvious effect on cytochrome P450 enzyme activities – which mediates CCl4 metabolism and participates in CCl4 toxicity [40–42].”
MethodInfluentialLi, X., Zheng, Q., Wang, Y., & Zhang, H. (2014) · Dalton Transactions · doi:10.1039/c4dt02065k · Cited by 29 · cited 1×
“Given the perceived prerequisite role for reductive metabolism of CCl4 to reactive intermediates using cytochrome P450 enzymes for CCl4 toxicity [39], cytochrome P450 enzymatic activ-Y ity was determined.”
BackgroundMulti-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis
Mercado-Gómez, M., Lopitz‐Otsoa, F., Azkargorta, M., Serrano‐Maciá, M., Lachiondo‐Ortega, S., Goikoetxea‐Usandizaga, N., Agudo, R. R., Fernández‐Ramos, D., Bizkarguenaga, M., Juan, V. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239043 · Cited by 29 · cited 1×
“Liver fibrosis refers to a devastating pathological process characterized by buildup of excess extracellular matrix proteins in a cadre of chronic liver diseases [1].”
BackgroundGárate‐Rascón, M., Recalde, M., Jiménez, M., Elizalde, M., Azkona, M., Uriarte, I., Latasa, M. U., Urtasun, R., Bilbao, I., Sangro, B., et al. (2021) · Hepatology · doi:10.1002/hep.32029 · Cited by 28 · cited 3×
“…observed using TEM in vivo, and MitoKeima in vitro) may contribute to hepatocyte ferroptosis in the face of CCl4 challenge, consistent with earlier findings that mitophagy promotes lipid peroxidation-induced ferroptosis through degradation of cargo contents within the cell [50,51,55,56].”
BackgroundYang, J. H., Ku, S., Cho, I. J., Lee, J. H., Na, C.-S., & Ki, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042041 · Cited by 23 · cited 1×
“…liver failure, cirrhosis, and hepatocellular carcinoma ensue, imposing a major threat for human health although little effective treatment remedy is readily available for patients with advanced liver fibrosis beyond liver transplantation due to its poorly defined underlying mechanism(s) [4,5].”
Background
Cited by
Lin, B., Wu, T., Nasb, M., Li, Z., & Chen, N. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.017 · Cited by 26
Metadata
- Authors
- Bi, Y., Liu, S., Qin, X., Abudureyimu, M., Wang, L., Zou, R., Ajoolabady, A., Zhang, W., Peng, H., Ren, J., & Zhang, Y.
- Venue
- Journal of Advanced Research
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 55
- Pages
- 45-60
- ISSN
- 2090-1224 (ISSN-L)
- 2090-1232
- OpenAlex
- W4321487204
- Cited by
- 213
- References
- 56
- FWCI
- 33.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.